Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M Molimard
From in Vitro to in Vivo: Intracellular Determination of Imatinib and Nilotinib May Be Related With Clinical Outcome
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
A Dose-Escalating Phase I of Imatinib Mesylate With Fixed Dose of Metronomic Cyclophosphamide in Targeted Olid Tumours
British Journal of Cancer
Cancer Research
Oncology
Related publications
Complete Molecular Response Induced by Nilotinib in a Patient Previously Treated With Imatinib, Nilotinib and Dasatinib
Clinical Management Issues
Medicine
Accounting
Management
Business
Response to Imatinib in Villonodular Pigmented Synovitis (PVNS) Resistant to Nilotinib
Clinical Sarcoma Research
Oncology
Imatinib May Be ABL to Improve Anti-Angiogenic Therapy
Molecular and Cellular Oncology
Cancer Research
Molecular Medicine
Evaluation of Nilotinib in Advanced GIST Previously Treated With Imatinib and Sunitinib
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Hyperoxia May Be Related to Delayed Cerebral Ischemia and Poor Outcome After Subarachnoid Haemorrhage
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
Nilotinib Übertrifft Imatinib in Der First-Line Weiterhin
Info Onkologie
In Vitro and in Vivo Determination of Anti-TNFα Activity in Canine Plasma From Donors Subject to Preconditioning With Endotoxin
Critical Care
Critical Care
Intensive Care Medicine
Long-Term Molecular and Cytogenetic Response and Survival Outcomes With Imatinib 400 Mg, Imatinib 800 Mg, Dasatinib, and Nilotinib in Patients With Chronic-Phase Chronic Myeloid Leukaemia: Retrospective Analysis of Patient Data From Five Clinical Trials
The Lancet Haematology
Hematology
Hypogonadism in Men With Erectile Dysfunction May Be Related to a Host of Chronic Illnesses
International Journal of Impotence Research
Urology
